Share on StockTwits

GI Dynamics (ASX:GID)‘s stock had its “add” rating restated by CIMB in a research note issued on Friday. They currently have a $1.04 target price on the stock.

GI Dynamics (ASX:GID) traded up 3.45% on Friday, hitting A$0.450. 510,280 shares of the company’s stock traded hands. GI Dynamics has a 52 week low of A$0.395 and a 52 week high of A$0.980. The stock’s 50-day moving average is A$0.45 and its 200-day moving average is A$0.56. The company’s market cap is A$213.2 million.

GI Dynamics, Inc is the developer and marketer of EndoBarrier, a device that represents an entirely new class of non-surgical, non-pharmaceutical therapy for the treatment of type 2 diabetes and obesity.

Receive News & Ratings for GI Dynamics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GI Dynamics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.